Current Urology Reports

, Volume 5, Issue 1, pp 65–72

Treatment of adrenocortical carcinoma: Contemporary outcomes

  • David Y. T. Chen
  • R. Ernest Sosa
  • Douglas S. Scherr

DOI: 10.1007/s11934-004-0014-x

Cite this article as:
Chen, D.Y.T., Sosa, R.E. & Scherr, D.S. Curr Urol Rep (2004) 5: 65. doi:10.1007/s11934-004-0014-x


Adrenocortical carcinoma is a rare cancer that historically has been associated with poor outcome. Throughout the past decades, growing experience has allowed better understanding of the natural history and optimal management of this cancer. Advances in imaging and aggressive surgical therapy have raised the outlook for recently diagnosed patients. Further improvements in survival will require more effective systemic therapy.

Copyright information

© Current Science Inc 2004

Authors and Affiliations

  • David Y. T. Chen
    • 1
  • R. Ernest Sosa
  • Douglas S. Scherr
  1. 1.Department of Urology, New York-Presbyterian HospitalWeill Cornell Medical CenterNew YorkUSA